Clinical Trial Update: Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL [NA]

View source ↗

Summary

A clinical trial comparing modified R-MINE versus R-GemOx regimens for late-relapsed diffuse large B-cell lymphoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)
• Mitoxantrone (mitoxantrone)
• OXALIPLATIN (Oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | NA | Status: NOT_YET_RECRUITING